DiNuzzo Private Wealth’s Biogen BIIB Stock Holding History

DiNuzzo Private Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.89K	Buy	18 +1	+6%	+$191	﹤0.01%	470
2026 Q1	$3.12K	Buy	17 +3	+21%	+$553	﹤0.01%	503
2025 Q4	$2.46K	Buy	14 +12	+600%	+$1.96K	﹤0.01%	573
2025 Q3	$265	Hold	2	–	–	﹤0.01%	1228
2025 Q2	$252	Sell	2 -30	-94%	-$3.74K	﹤0.01%	1214
2025 Q1	$4.38K	Sell	32 -5	-14%	-$715	﹤0.01%	383
2024 Q4	$5.66K	Sell	37 -7	-16%	-$1.18K	﹤0.01%	328
2024 Q3	$8.53K	Buy	44 +30	+214%	+$6.28K	﹤0.01%	277
2024 Q2	$3.25K	Buy	14 +1	+8%	+$217	﹤0.01%	379
2024 Q1	$2.8K	Sell	13 -2	-13%	-$468	﹤0.01%	368
2023 Q4	$3.88K	Buy	+15	New	+$3.68K	﹤0.01%	277

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

DiNuzzo Private Wealth's BIIB Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its Biogen (BIIB) stake by 5.9% in Q2 2026, buying an estimated $191 and bringing the position to 18 shares worth $3.89K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

DiNuzzo Private Wealth first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.53K in Q3 2024. 362 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

DiNuzzo Private Wealth held 18 shares of Biogen worth $3.89K as of Q2 2026.
DiNuzzo Private Wealth bought 1 Biogen share in Q2 2026, an estimated $191.
Biogen made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #470 holding.
DiNuzzo Private Wealth first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
DiNuzzo Private Wealth's Biogen position peaked at $8.53K in Q3 2024.
362 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.